Skip to content
Subscribe
Submit an Article
Search
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts
  • Home
  • News
  • Videos
  • Conference Coverage
  • Podcasts

Day: July 25, 2025

What Will the U.S. FDA Nod for Delgocitinib Cream (Anzupgo) Mean for Your CHE Patients?

Robert Spurr, CEO and President of LEO Pharma Inc., discusses the U.S. Food and Drug Administration’s recent nod for delgocitinib cream (Anzupgo) in chronic hand eczema.

The Journal of Dermatology for Nurse Practitioners (NPs) and Physician Assistants (PAs) or JDNPPA is an independent, omni-channel resource that is for NPs and PAs and by NPs and PAs.

Linkedin Facebook-f Instagram X-twitter
Quick Links
  • Advertise with Us
  • About Us
  • Advertise with Us
  • About Us

© 2025 All Rights Reserved.